Drug comparisons
Donislecel vs Troglitazone
Donislecel (Lantidra) vs Troglitazone: Cell therapy for T1D vs withdrawn oral TZD for T2D. Compare uses, risks, and current availability.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when reviewing current cell-based options for type 1 diabetes against discontinued thiazolidinediones formerly used in type 2 diabetes.
Bottom line
Donislecel and Troglitazone treat distinct diabetes types and Troglitazone is no longer available due to safety issues.
All medication comparisons